Myopathy due to myoadenylate deaminase deficiency

General Information (adopted from Orphanet):

Synonyms, Signs:
Number of Symptoms 18
OrphanetNr:
OMIM Id: 615511
ICD-10:
UMLs:
MeSH:
MedDRA:
Snomed:

Prevalence, inheritance and age of onset:

Prevalence: No data available.
Inheritance: Autosomal recessive
23622405 [IBIS]
Age of onset: Childhood
Adult
23622405 [IBIS]

Disease classification (adopted from Orphanet):

Parent Diseases: AARSKOG SYNDROME, AUTOSOMAL DOMINANT
 -AARSKOG SYNDROME, AUTOSOMAL DOMINANT

Comment:

Inherited myoadenylate deaminase (mAMPD) has heterogenous clinical manifestations. The vast majority of individuals with mAMPD deficiency are asymptomatic (PMID:23622405).

Symptom Information: Sort by abundance 

1
(HPO:0002189) Excessive daytime sleepiness 26439223 IBIS 8 / 7739
2
(HPO:0003738) Exercise-induced myalgia 10996775; 1631143; 26439223 IBIS 19 / 7739
3
(HPO:0012378) Fatigue 26439223 IBIS 50 / 7739
4
(HPO:0100786) Hypersomnia 26439223 IBIS 4 / 7739
5
(HPO:0003546) Exercise intolerance 23622405; 26439223 IBIS 62 / 7739
6
(HPO:0003201) Rhabdomyolysis rare [HPO:skoehler] 1631143; 26439223 IBIS 27 / 7739
7
(HPO:0003750) Increased muscle fatiguability 1631143 IBIS 8 / 7739
8
(HPO:0001324) Muscle weakness 10996775; 1631143 IBIS 859 / 7739
9
(HPO:0003326) Myalgia 23622405; 1631143 IBIS 143 / 7739
10
(HPO:0001315) Reduced tendon reflexes 10996775 IBIS 160 / 7739
11
(HPO:0001252) Muscular hypotonia rare [HPO:skoehler] 10996775 IBIS 990 / 7739
12
(HPO:0003391) Gowers sign 10996775 IBIS 37 / 7739
13
(HPO:0002515) Waddling gait 10996775 IBIS 56 / 7739
14
(HPO:0002317) Unsteady gait 10996775 IBIS 45 / 7739
15
(HPO:0003202) Skeletal muscle atrophy 10996775 IBIS 281 / 7739
16
(HPO:0003236) Elevated serum creatine phosphokinase 23622405 IBIS 214 / 7739
17
(HPO:0008305) Exercise-induced myoglobinuria 23622405 IBIS 7 / 7739
18
(HPO:0003710) Exercise-induced muscle cramps 23622405 IBIS 11 / 7739

Associated genes:

AMPD1;

ClinVar (via SNiPA)

Gene symbol Variation Clinical significance Reference

Additional Information: